JULPHAR - Gulf Pharmaceutical Industries

 Home | New Investors | company results | Companies | UAE Brokers | Stock Forum | Latest posts | UAE news

Forum Topics
Recent News
Comments
Financial Reports
Contact and Links
          

Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com

Share prices in AED | Chart help
Interactive Stock Charts provided by WD SOFTWARE

Share price 15 Apr 2009 1.36 dhs
Price/earnings (annualised)
Latest report JULPHAR 2008 M9 report
Stock market Abu Dhabi Securities Exchange
Founding date 30 Mar 1980 Listing date 19 Oct 2002
Auditor Talal Abu-Ghazaleh & Co International
Chairman of JULPHAR Shaikh Faisal Bin Saqr Al Qasimi
CEO of JULPHAR Abdul Razzaq Yousef
Foreign ownership limit Maximum 49%
Total shares outstanding 641,042,000
Market capitalisation (AED) 871,817,120
Par value 1 Dh per share
Dividends for 2013 FY
Cash dividend yield
Fair Value estimate
Share price rating  
Difference from fair value
Consider buying below
Consider selling above
Latest share data for JULPHAR orders | trades | chart
Ratings, estimates, comments are opinions only, and are not to be taken as advice to buy, sell or hold shares. E&OE.
JULPHAR reports
* annualised
Date Profit
AED
EPS
AED
EPS*
AED
Price
AED
PE* PBV ROE* ROS
JULPHAR 2008 Q3 29 Oct 2008 10.4m 0.02 0.06 1.73 26.7 0.9 3.2% 7.4%
JULPHAR 2008 Q2 20 Jul 2008 79.5m 0.12 0.50 2.31 4.7 1.2 26.2%  
JULPHAR 2008 Q1 27 Apr 2008 42.7m 0.07 0.27 2.36 8.9 1.2 14.1% 27.2%
JULPHAR 2007 FY 03 Jan 2008 207m 0.34 0.34 2.63 7.8 1.4 18.4% 31.3%
JULPHAR 2007 Q3 29 Oct 2007 42.9m 0.07 0.28 2.08 7.4 1.1 15.2% 28.6%
JULPHAR 2007 Q2 30 Jul 2007 31.2m 0.05 0.20 1.98 9.7 1.1 11.5% 19.9%
JULPHAR 2007 Q1 19 Apr 2007 31.1m 0.06 0.24 2.71 11.2 1.6 14.1% 17.7%
JULPHAR 2006 FY 29 Jan 2007 66.7m 0.13 0.13 2.05 15.9 1.2 7.3% 10.9%
JULPHAR 2005 FY 117m           15.5% 21.5%
JULPHAR 2004 FY 67.1m              
Share price 15 Apr 2009 1.36 dhs
Price/earnings (annualised)
Latest report JULPHAR 2008 M9 report
Stock market Abu Dhabi Securities Exchange
Founding date 30 Mar 1980 Listing date 19 Oct 2002
Auditor Talal Abu-Ghazaleh & Co International
Chairman of JULPHAR Shaikh Faisal Bin Saqr Al Qasimi
CEO of JULPHAR Abdul Razzaq Yousef
Foreign ownership limit Maximum 49%
Total shares outstanding 641,042,000
Market capitalisation (AED) 871,817,120
Par value 1 Dh per share
Dividends for 2013 FY
Cash dividend yield
Fair Value estimate
Share price rating  
Difference from fair value
Consider buying below
Consider selling above
Latest share data for JULPHAR orders | trades | chart
Ratings, estimates, comments are opinions only, and are not to be taken as advice to buy, sell or hold shares. E&OE.
JULPHAR reports
* annualised
Date Profit
AED
EPS
AED
EPS*
AED
Price
AED
PE* PBV ROE* ROS
JULPHAR 2008 Q3 29 Oct 2008 10.4m 0.02 0.06 1.73 26.7 0.9 3.2% 7.4%
JULPHAR 2008 Q2 20 Jul 2008 79.5m 0.12 0.50 2.31 4.7 1.2 26.2%  
JULPHAR 2008 Q1 27 Apr 2008 42.7m 0.07 0.27 2.36 8.9 1.2 14.1% 27.2%
JULPHAR 2007 FY 03 Jan 2008 207m 0.34 0.34 2.63 7.8 1.4 18.4% 31.3%
JULPHAR 2007 Q3 29 Oct 2007 42.9m 0.07 0.28 2.08 7.4 1.1 15.2% 28.6%
JULPHAR 2007 Q2 30 Jul 2007 31.2m 0.05 0.20 1.98 9.7 1.1 11.5% 19.9%
JULPHAR 2007 Q1 19 Apr 2007 31.1m 0.06 0.24 2.71 11.2 1.6 14.1% 17.7%
JULPHAR 2006 FY 29 Jan 2007 66.7m 0.13 0.13 2.05 15.9 1.2 7.3% 10.9%
JULPHAR 2005 FY 117m           15.5% 21.5%
JULPHAR 2004 FY 67.1m              

JULPHAR opinion, news, reports, researchTop


Fatal error: Call to undefined function message_die() in /home/dubaisha/public_html/viewforum-sw.php on line 104

JULPHAR latest news (links open in new window)Top

News Item

Research and Markets Offers Report: Saudi Pharmaceuticals Market ... Insurance News Net The country is one of the most developed and technologically advanced medical sectors in the GCC region with modern equipment and amenities. Companies Mentioned. - Astra. -GSK. -Jamjoom Pharma. - Julphar ( Gulf Pharmaceutical Industries ). - Novartis. More ...


News Item

Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 ... DigitalJournal.com The Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast toá... More ...


News Item

Dangote to Address Leaders at 2nd Africa Global Business Forum in Dubai THISDAY Live President of Dangote Group of Companies, Alhaji Aliko Dangote, has confirmed his presence as one of the speakers at the second two-day Africa Global Business Forum, taking place on October 1st and 2nd in Dubai. Dangote, Africa's richest man, whoseá... More ...


News Item

Research and Markets Adds Report: Saudi Pharmaceuticals Market ... Insurance News Net The country is one of the most developed and technologically advanced medical sectors in the GCC region with modern equipment and amenities. Companies Mentioned. - Astra. -GSK. -Jamjoom Pharma. - Julphar ( Gulf Pharmaceutical Industries ). - Novartis. and moreá╗ More ...


News Item

The National Greenfield FDI in the UAE picks up the pace and tops $6 billion The National Foreign direct investment into the UAE is picking up pace but remains short of its pre-crisis peak. The UAE received US$6.2 billion in greenfield foreign direct investment (FDI) last year as overall foreign investment flows into the country increased for the fourthá... More ...


News Item

DailyPost Nigeria Aliko Dangote to speak at the 2nd Africa Global Business Forum in Dubai DailyPost Nigeria Aliko Dangote, Africa's richest man, whose business activities drive economic growth across the continent has confirmed his presence at the 2nd Africa Global Business Forum, taking place on October 1st and 2nd in Atlantis The Palm, Dubai. Mr. Dangote willá... and moreá╗ More ...


News Item

Julphar H1 profits up 10.4% Emirates 24/7 RAK-based pharmaceuticals firm Julphar has posted a 10.43 per cent year-on-year rise in its first-half gross profits for 2014, the firm said in a media statement. Gross profit during the first half of 2014 was Dh455.1 million while gross profit for the secondá... More ...


News Item

Research and Markets: Saudi Pharmaceuticals Market Development Analysis ... Rock Hill Herald (press release) Pharmaceuticals products sales in Saudi Arabia are expected to surpass US$ 7 Billion by 2018 as compared to US$ 4.40 Billion in 2013. The Saudi Arabia Pharmaceutical market has recorded significant growth over the years driven by various factors like aná... and moreá╗ More ...


News Item

gulfnews.com DFM falls 0.17% as trade values remain low gulfnews.com In Abu Dhabi, Ras Al Khaimah Ceramic Co. topped the gainers' list with a 7.36 per cent change, followed by Gulf Pharmaceutical Industries ( Julphar ) with 4.32 per cent, Methaq Takaful Insurance Co. with 2.65 per cent, and Abu Dhabi Ship Building Co. withá... and moreá╗ More ...


News Item

Financial results for second quarter of 2014 AME Info (press release) (blog) Tuesday, August 12 - 2014 @ 16:32. Julphar registered sales revenue of AED 761.7 million in the first half of the year 2014, up 9.39% year-on-year (yoy). Sales during the second quarter were driven by private market sales which saw a yoy growth of 13.9%. More ...


Newsfeed from Google News. See also latest UAE market news.

JULPHAR opinion, news, reports, researchTop


Fatal error: Call to undefined function message_die() in /home/dubaisha/public_html/viewforum-sw.php on line 104
Julphar financial statements & accountsTop
PDF files (new window) 2004 2005 2006 2007 2008
JULPHAR First Quarter 2004Q1 2005Q1 2006Q1 2007Q1 2008Q1
JULPHAR Second Quarter 2004Q2 2005Q2 2006Q2 2007Q2 2008Q2
JULPHAR Third Quarter 2004Q3 2005Q3 2006Q3 2007Q3  2008Q3
JULPHAR Preliminary FY Report 2004PR 2005PR 2006PR  2007PR   
JULPHAR Final Annual Report 2004FY 2005FY 2006FY 2007FY

Links are to the relevant PDF report on the ESCA website and are provided as a convenience by ShareWadi.com. We are not responsible for the content or availability of any external sites or pages. If accounts are not available from ESCA, try the ADX or DFM website.

JULPHAR latest news (links open in new window)Top

News Item

Research and Markets Offers Report: Saudi Pharmaceuticals Market ... Insurance News Net The country is one of the most developed and technologically advanced medical sectors in the GCC region with modern equipment and amenities. Companies Mentioned. - Astra. -GSK. -Jamjoom Pharma. - Julphar ( Gulf Pharmaceutical Industries ). - Novartis. More ...


News Item

Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 ... DigitalJournal.com The Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast toá... More ...


News Item

Dangote to Address Leaders at 2nd Africa Global Business Forum in Dubai THISDAY Live President of Dangote Group of Companies, Alhaji Aliko Dangote, has confirmed his presence as one of the speakers at the second two-day Africa Global Business Forum, taking place on October 1st and 2nd in Dubai. Dangote, Africa's richest man, whoseá... More ...


News Item

Research and Markets Adds Report: Saudi Pharmaceuticals Market ... Insurance News Net The country is one of the most developed and technologically advanced medical sectors in the GCC region with modern equipment and amenities. Companies Mentioned. - Astra. -GSK. -Jamjoom Pharma. - Julphar ( Gulf Pharmaceutical Industries ). - Novartis. and moreá╗ More ...


News Item

The National Greenfield FDI in the UAE picks up the pace and tops $6 billion The National Foreign direct investment into the UAE is picking up pace but remains short of its pre-crisis peak. The UAE received US$6.2 billion in greenfield foreign direct investment (FDI) last year as overall foreign investment flows into the country increased for the fourthá... More ...


News Item

DailyPost Nigeria Aliko Dangote to speak at the 2nd Africa Global Business Forum in Dubai DailyPost Nigeria Aliko Dangote, Africa's richest man, whose business activities drive economic growth across the continent has confirmed his presence at the 2nd Africa Global Business Forum, taking place on October 1st and 2nd in Atlantis The Palm, Dubai. Mr. Dangote willá... and moreá╗ More ...


News Item

Julphar H1 profits up 10.4% Emirates 24/7 RAK-based pharmaceuticals firm Julphar has posted a 10.43 per cent year-on-year rise in its first-half gross profits for 2014, the firm said in a media statement. Gross profit during the first half of 2014 was Dh455.1 million while gross profit for the secondá... More ...


News Item

Research and Markets: Saudi Pharmaceuticals Market Development Analysis ... Rock Hill Herald (press release) Pharmaceuticals products sales in Saudi Arabia are expected to surpass US$ 7 Billion by 2018 as compared to US$ 4.40 Billion in 2013. The Saudi Arabia Pharmaceutical market has recorded significant growth over the years driven by various factors like aná... and moreá╗ More ...


News Item

gulfnews.com DFM falls 0.17% as trade values remain low gulfnews.com In Abu Dhabi, Ras Al Khaimah Ceramic Co. topped the gainers' list with a 7.36 per cent change, followed by Gulf Pharmaceutical Industries ( Julphar ) with 4.32 per cent, Methaq Takaful Insurance Co. with 2.65 per cent, and Abu Dhabi Ship Building Co. withá... and moreá╗ More ...


News Item

Financial results for second quarter of 2014 AME Info (press release) (blog) Tuesday, August 12 - 2014 @ 16:32. Julphar registered sales revenue of AED 761.7 million in the first half of the year 2014, up 9.39% year-on-year (yoy). Sales during the second quarter were driven by private market sales which saw a yoy growth of 13.9%. More ...


Newsfeed from Google News. See also latest UAE market news.

Julphar comments & notesTop

Gulf Pharmaceuticals is a cosmetic, drugs, and medicine manufacturing company. Although it was incorporated at the end of March 1980, it did not start commercial operations until November 1984.

Subsidiaries and stakes in other companies

  • Awafi Drug Store - direct sales of pharmaceuticals (sold to Planet Pharmacies in Dec 2007)
  • Julphar Drug Stores, UAE - distribution network for Julphar products (sold to Planet Pharmacies in Dec 2007)
  • Julphar Pharmacies, UAE - direct selling of Julphar drugs and cosmetics
  • Julphar Pharma Factory, Germany - production facility for medical and pharmaceutical cosmetics
  • Planet Pharmacies, Dubai, UAE (40%) - chain of retail outlets, JV with Global Investment House
  • Scientific Pharmacy, Oman - distribution agent and direct selling of Julphar products
  • SMS Pharmaceuticals, India (12.2%)
Julphar share capital, shares outstanding, AGM dates, dividends
  • 27 April 2008 - dividend record date
  • 17 April 2008 - AGM approved 10% cash & 5% share dividends
  • 31 March 2008 - AED 641,042,000 share capital (641.042 million shares outstanding) - 5% bonus shares (30.526 million) for 2007FY included
  • 31 December 2007 - AED 610,516,000 share capital
  • 31 March 2007 - AED 516,016,000 share capital
  • 31 December 2007 - AED 516,016,000 share capital
28 April 2008 - Julphar CEO
  • Abdul Razzak Yousef is listed as Chief Executive Officer (CEO) on 08Q1 balance sheet (& 07FY). Previously he was listed as the Managing Director. Unknown when change occured.
January 2008 - further capital increase and expansion plans
  • A report in Emirates Business said that Julphar would increase capital to AED 1 billion in a series of share issues from 2008-2010, at a price of 1.75 dhs per share (par value + 0.75 dhs premium).
  • Julphar expansion plans from 2008-2010 include investment of AED 1.2 billion in joint ventures towards construction of new plants in Afghanistan, Iran, Lebanon, Morocco, Sudan, Yemen.
  • Julphar is also expanding in Ras Al Khaimah with a reported 7 new plants opening there - two plants are scheduled to open in April 2008, three in 2009, and two in 2010.
  • Julphar also has expansion plans for, and agreements with companies in, Indonesia, Malaysia, the Philippines, Turkey. A previous report mentioned Bangladesh and India as other markets in which Julphar was setting up a prescence, or entering into supply and distribution agreements with local entities.
13 December 2007 - Planet Pharmacies

Julphar and Global Investment House (GLOBAL), a Kuwait based company with a secondary listing on the Dubai Financial Market, announced they would set up Planet Pharmacies LLC in Dubai, a holding company for a chain of retail outlets for pharmaceutical and healthcare products. They intend for Planet Pharmacies to be the largest chain in the Middle East. Initial operations will start with a reported (by the Khaleej Times) 65 pharmacies in the UAE and another 18 in Oman, expanding to about 2000 retail outlets by 2010. Initial capital would be AED 900 million, increasing to AED 3 billion, with a 40:60 ownership between Julphar and Global.

01 May 2007 - capital increase
  • A further 94,500,188 shares were issued to bring the total up to 610,516,188 shares outstanding from 516,016,000.
07 February 2007 - investment in India's SMS Pharmaceuticals

Julphar acquired a 12.2% equity stake in SMS Pharmaceuticals Ltd of India. SMS produces Ranitidine HCL and is an FDA approved manufacturer of Active Pharmaceutical Ingredients (API). Value of the deal was given as 300 million Rupees.

August 2006 - capital increase
  • Rights issue of 53,776,000 shares at par + 0.75 fils per share premium. Total shares outstanding 516,016,000
05 April 2006 - AGM approves capital increase and bonus shares
  • Shares outstanding increased from 385,200,000 to 462,240,000 shares via 20% share dividend
  • Capital increase of 537,760,000 dhs to take total capital to AED 1 billion
Contact details and investor informationTop
  • Julphar, PO Box 997, Ras Al Khaimah, UAE. Tel +971-7-2461461.
  • www.julphar.com - JULPHAR website home page.
  • julphar@emirates.net.ae - Julphar email.
JULPHAR - related external links (open in new window)Top
  • www.sca.ae - ESCA profile. Includes share ownership details, board of director names, meeting dates, financial statements and annual report.
  • www.adx.ae - ADX financial disclosures, news and information.

Disclaimer: ShareWadi.com and DubaiShareTalk.com provide UAE stockmarket related information, but do not offer investment advisory services, or brokerage services. Investing in shares is risky, you can lose some or all of your money and/or other assets. Anything you read on this site should be regarded as the opinion of the author only and is not to be taken as advice to buy, sell, or hold shares and/or other investments. Do not make investment decisions without due diligence and/or professional advice. In particular, do not assume anything you read on this site is correct or accurate. You should make your own investigations to determine if information is accurate and ultimately, you should accept that you and you alone are responsible for any investing decisions you make.

daily market reports | Calendar | Abu Dhabi Securities Exchange | Dubai Financial Market | ADSM DFM forms | Links | news & research | UAE IPO
RSS (daily market report) | DFM ADSM forum | FAQs | Dubai stock exchange | Contact Us | About Us | Terms of Service | Privacy Policy | Advertise

Copyright © ShareWadi.com 2005-2008. Any company names or product names used on this site, discussion forum, and/or communications from anyone associated with this website are the trademarks or registered trademarks of their respective holders.
This page last updated 26-Nov-2009. Company information last updated 24 Jun 2008. E & OE.